Catalyst Wire Dossier Catalyst Wire Dossier

Visugromab

Visugromab · CatalYm GmbH
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Visugromab, covering 2025-10-21 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Visugromab in Cachexia International Trial [Phase 2, Phase 3]

See pricing